A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2019

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

(1) , (2) , (3) , , (4) , (5) , , , (6) , (7) , , , , , (8) , (9, 10) , , , (11) , (12)
1
2
3
4
5
6
7
8
9
10
11
12

Dates et versions

hal-03598661 , version 1 (05-03-2022)

Identifiants

Citer

K. Fizazi, A. Maillard, N. Penel, G. Baciarello, D. Allouache, et al.. A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04). Annals of Oncology, 2019, 30 (5), pp.851. ⟨10.1093/annonc/mdz394⟩. ⟨hal-03598661⟩
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More